These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 32572516)

  • 21. Audio Interview: Studying Potential Covid-19 Therapies.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 May; 382(19):e72. PubMed ID: 32379957
    [No Abstract]   [Full Text] [Related]  

  • 22. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.
    Wang M; Cao R; Zhang L; Yang X; Liu J; Xu M; Shi Z; Hu Z; Zhong W; Xiao G
    Cell Res; 2020 Mar; 30(3):269-271. PubMed ID: 32020029
    [No Abstract]   [Full Text] [Related]  

  • 23. When the Others Become Us: A Chemist's Perspective of the COVID-19 Outbreak in Italy.
    Kiessling L; MacLaughlin C; Sattin S
    ACS Chem Biol; 2020 Jun; 15(6):1279-1281. PubMed ID: 32383582
    [No Abstract]   [Full Text] [Related]  

  • 24. Drug repositioning is an alternative for the treatment of coronavirus COVID-19.
    Serafin MB; Bottega A; Foletto VS; da Rosa TF; Hörner A; Hörner R
    Int J Antimicrob Agents; 2020 Jun; 55(6):105969. PubMed ID: 32278811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.
    Wang Y; Zhang D; Du G; Du R; Zhao J; Jin Y; Fu S; Gao L; Cheng Z; Lu Q; Hu Y; Luo G; Wang K; Lu Y; Li H; Wang S; Ruan S; Yang C; Mei C; Wang Y; Ding D; Wu F; Tang X; Ye X; Ye Y; Liu B; Yang J; Yin W; Wang A; Fan G; Zhou F; Liu Z; Gu X; Xu J; Shang L; Zhang Y; Cao L; Guo T; Wan Y; Qin H; Jiang Y; Jaki T; Hayden FG; Horby PW; Cao B; Wang C
    Lancet; 2020 May; 395(10236):1569-1578. PubMed ID: 32423584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Probable Molecular Mechanism of Remdesivir for the Treatment of COVID-19: Need to Know More.
    Saha A; Sharma AR; Bhattacharya M; Sharma G; Lee SS; Chakraborty C
    Arch Med Res; 2020 Aug; 51(6):585-586. PubMed ID: 32439198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COVID-19: Rescue by transcriptional inhibition.
    Shilatifard A
    Sci Adv; 2020 Jul; 6(27):. PubMed ID: 32937442
    [No Abstract]   [Full Text] [Related]  

  • 28. [Remdesivir for patients with severe COVID-19].
    Augustin M; Hallek M; Nitschmann S
    Internist (Berl); 2020 Jun; 61(6):644-645. PubMed ID: 32333086
    [No Abstract]   [Full Text] [Related]  

  • 29. Efficacy of Remdesivir in COVID-19.
    McCreary EK; Angus DC
    JAMA; 2020 Sep; 324(11):1041-1042. PubMed ID: 32821934
    [No Abstract]   [Full Text] [Related]  

  • 30. Case report study of the first five COVID-19 patients treated with remdesivir in France.
    Dubert M; Visseaux B; Isernia V; Bouadma L; Deconinck L; Patrier J; Wicky PH; Le Pluart D; Kramer L; Rioux C; Le Hingrat Q; Houhou-Fidouh N; Yazdanpanah Y; Ghosn J; Lescure FX
    Int J Infect Dis; 2020 Sep; 98():290-293. PubMed ID: 32619764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pulmonary administration of remdesivir in the treatment of COVID-19.
    Rasmussen HB; Hansen PR; Taboureau O; Thomsen R; Jürgens G
    AAPS J; 2020 Sep; 22(6):121. PubMed ID: 32944838
    [No Abstract]   [Full Text] [Related]  

  • 32. Kidney Transplantation and COVID-19.
    Merhi B; Gohh R
    R I Med J (2013); 2020 Sep; 103(8):34-37. PubMed ID: 32900010
    [No Abstract]   [Full Text] [Related]  

  • 33. A Review of Remdesivir for COVID-19: Data to Date.
    Mehta M; Shyh GI
    Cardiol Rev; 2020; 28(6):332-334. PubMed ID: 32773440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Remdesivir for the Treatment of Covid-19 - Preliminary Report.
    Gillenwater S; Rahaghi F; Hadeh A
    N Engl J Med; 2020 Sep; 383(10):992. PubMed ID: 32649074
    [No Abstract]   [Full Text] [Related]  

  • 35. Remdesivir for the Treatment of Covid-19 - Preliminary Report.
    McMahon JH; Udy A; Peleg AY
    N Engl J Med; 2020 Sep; 383(10):992-993. PubMed ID: 32649075
    [No Abstract]   [Full Text] [Related]  

  • 36. Remdesivir for the Treatment of Covid-19 - Preliminary Report.
    McCaw ZR; Kim DH; Wei LJ
    N Engl J Med; 2020 Sep; 383(10):993. PubMed ID: 32649076
    [No Abstract]   [Full Text] [Related]  

  • 37. Remdesivir for the Treatment of Covid-19 - Preliminary Report.
    Olalla J
    N Engl J Med; 2020 Sep; 383(10):993-994. PubMed ID: 32649077
    [No Abstract]   [Full Text] [Related]  

  • 38. Remdesivir in COVID-19: A critical review of pharmacology, pre-clinical and clinical studies.
    Singh AK; Singh A; Singh R; Misra A
    Diabetes Metab Syndr; 2020; 14(4):641-648. PubMed ID: 32428865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Remdesivir for the Treatment of Covid-19 - Preliminary Report. Reply.
    Beigel JH; Tomashek KM; Dodd LE
    N Engl J Med; 2020 Sep; 383(10):994. PubMed ID: 32649078
    [No Abstract]   [Full Text] [Related]  

  • 40. Communicating Science in the Time of a Pandemic.
    Saitz R; Schwitzer G
    JAMA; 2020 Aug; 324(5):443-444. PubMed ID: 32749498
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.